QI Yu-feng, SHAO Qiang, SHEN Bing. Correlation analysis of CAT score with lung function and blood gas analysis in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2021, 19(9): 1504-1506. doi: 10.16766/j.cnki.issn.1674-4152.002097
Citation: QI Yu-feng, SHAO Qiang, SHEN Bing. Correlation analysis of CAT score with lung function and blood gas analysis in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2021, 19(9): 1504-1506. doi: 10.16766/j.cnki.issn.1674-4152.002097

Correlation analysis of CAT score with lung function and blood gas analysis in patients with chronic obstructive pulmonary disease

doi: 10.16766/j.cnki.issn.1674-4152.002097
Funds:

 81570403

  • Received Date: 2020-06-21
    Available Online: 2022-02-15
  •   Objective  To investigate the relationship between pulmonary function, blood gas analysis, pulmonary systolic pressure and CAT score in patients with chronic obstructive pulmonary disease (COPD).   Methods  Total 106 patients with COPD admitted to the Department of Perspiratory Medicine of Lu'an People's Hospital from September to December 2019 were classified into mild group (11 cases), moderate group (28 cases), severe group (41 cases) and very severe group (26 cases) according to CAT score. The pulmonary function of COPD patients in different disease states, including FEV1, FVC, PEF, PaO2, PaCO2, and sPAP were compared, and the correlation between each index and CAT score was discussed.   Results  The lower the cat score, the lung function indexes were higher (FEV1, FEV1/FVC, PEF) (all P < 0.05); The lower cat score was, the PaO2 was higher, the PaCO2 was lower (all P < 0.05), and the sPAP was lower (P < 0.05); Especially in patients with cat score >20, the above differences were particularly significant. Pearson correlation analysis shown that FEV1%, FEV1/FVC, PEF% and PaO2 were negatively correlated with CAT score, while PaCO2 and sPAP were positively correlated with CAT score.   Conclusion  The CAT score of COPD patients was correlated with pulmonary function, pulmonary artery systolic pressure and blood gas analysis. It is proved that CAT score can effectively predict the air exchange dysfunction and ventilation dysfunction of COPD patients, and evaluate the pulmonary function of COPD patients.

     

  • [1]
    胡维, 眭建. 社区医院有关慢性阻塞性肺疾病现况的调查[J]. 中华全科医学, 2015, 13(10): 1658-1660. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201510037.htm
    [2]
    WIKLUND I, BERRY P, LU K X, et al. The Chinese translation of COPD Assessment TestTM(CAT) provides valid and reliable measurement of COPD health status in Chinese COPD patients[J]. AM J Respir Crit Med, 2010. DOI: 10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3575.
    [3]
    中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸病杂志, 2018, 36(4): 255-264. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201402028.htm
    [4]
    SIN D D, WU L L, MAN S F P. The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature[J]. Chest, 2005, 127(6): 1952-1959. doi: 10.1378/chest.127.6.1952
    [5]
    LABAKI W W, HAN M K. Improving detection of early chronic obstructive pulmonary disease[J]. Ann Am Thorac Soc, 2018, 15(Suppl 4): S243-S248.
    [6]
    SCHERMER T R, ROBBERTS B, CROCKETT A J, et al. Should the diagnosis of COPD be based on a single spirometry test?[J]. NPJ Prim Care Respir Med, 2016, 26: 16059. doi: 10.1038/npjpcrm.2016.59
    [7]
    DE MARCO V G, HABIBI J, WHALEY-CONNELL A T, et al. Oxidative stresscontributes to pulmonary hypertension in the transgenic(mRen2)27 rat[J]. Am J Physiol Heart Circ Physiol, 2008, 294(6): 2659-2668. doi: 10.1152/ajpheart.00953.2007
    [8]
    SEEGER W, ADIR Y, BARBERÀ J A, et al. Pulmonary hypertension in chronic lung diseases[J]. J Am Coll Cardiol, 2013, 62(25): D109-116. doi: 10.1016/j.jacc.2013.10.036
    [9]
    ALLINSON J P, HARDY R, DONALDSON G C, et al. The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development[J]. Am J Respir Crit Care Med, 2016, 193(6): 662-672. doi: 10.1164/rccm.201511-2210OC
    [10]
    乔智灏, 刘昶, 张梦雅. 痰热清注射液联合噻托溴铵对尘肺病合并慢性阻塞性肺疾病患者呼吸功能的影响[J]. 中华全科医学, 2019, 17(3): 409-412. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201903020.htm
    [11]
    杨建民, 郑喜文, 陈雪, 等. CAT、mMRC评分在评估COPD患者分组中的差异性研究[J]. 中华全科医学, 2017, 15(7): 1181-1184. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201707028.htm
    [12]
    宋雅君, 周哲慧, 柳耀康, 等. 慢性阻塞性肺疾病稳定期患者肺功能、血气分析指标与CAT评分的相关性分析[J]. 医学临床研究杂志, 2018, 35(2): 312-313. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF201907005.htm
    [13]
    MAKUCH M, MILANOWSKA J, MICHNAR M, et al. The relationship between COPD Assessment Test (CAT) scores and Distress Thermometer (DT) results in COPD patients[J]. Ann Agric Enviro Med, 2020, 27(4): 689-694. doi: 10.26444/aaem/114103
    [14]
    SINGH D, AGUSTI A, ANZUETO A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019[J]. Eur Respir J, 2019, 53(5): 1900164. doi: 10.1183/13993003.00164-2019
    [15]
    HANSEN H, BIELER T, BEYER N, et al. Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: A randomised multicentre trial[J]. Thorax, 2020, 75(5): 413-421. doi: 10.1136/thoraxjnl-2019-214246
    [16]
    YE W, LI X, GU W, et al. A comparison of diagnostic consistency for asthma-chronic obstructive pulmonary disease overlap and clinical characteristics study[J]. BMC Pulm Med, 2019, 19(1): 249-257. doi: 10.1186/s12890-019-1024-2
    [17]
    SIMONNEAAU G, MONTANI D, CELELERMAJER D S, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801913. doi: 10.1183/13993003.01913-2018
    [18]
    STOLL P, FOERSTER S, VIRCHOW C J, et al. Overweight is a predictor of long-term survival in hospitalised patients with exacerbations of COPD[J]. Respir Med, 2016, 116: 59-62. doi: 10.1016/j.rmed.2016.05.016
    [19]
    CARONE M, ANTONIUS S, BAIARDI P, et al. Predictors of Mortality in patients with COPD and chronic respiratory failure: The quality-of-life evaluation and survival study (QuESS): A three-year study[J]. COPD, 2015, 13(2): 130-138. http://www.researchgate.net/profile/Giorgio_Bertolotti/publication/283687454_Predictors_of_Mortality_in_Patients_with_COPD_and_Chronic_Respiratory_Failure_The_Quality-of-Life_Evaluation_and_Survival_Study_QuESS_A_Three-Year_Study/links/566e9ebd08ae430ab5002e0e.pdf
    [20]
    GARCLA S P, NAVAL E, MARTINEZ R C, et al. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations[J]. Respir MED, 2015, 109(12): 1546-1552. doi: 10.1016/j.rmed.2015.10.011
  • Cited by

    Periodical cited type(27)

    1. 张玄,陈园园,张国英,王静,李姗姗,王建春. 白葡奈氏菌片联合ICS+LABA治疗中重度COPD急性发作. 中国卫生标准管理. 2024(01): 147-151 .
    2. 蔡晨盛,杜茜. COPD患者膈肌形态超声指标数值与其肺功能的相关性研究. 现代医用影像学. 2024(01): 48-51 .
    3. 张津浩,陈彦超,徐楠,喻文定,李鸣翰,饶力群,彭国平,汪启明. 基于网络药理学和分子对接探究喻氏凉茶抗炎的作用机理. 特产研究. 2024(01): 62-71 .
    4. 王哲伟,叶思思,张中凯,林秀秀. 胸部物理治疗联合下肢运动训练对AECOPD患者的疗效. 江苏医药. 2024(01): 59-62 .
    5. 葛云芳,高聪慧,王景娜,张力. 益生菌对老年慢性阻塞性肺疾病患者的疗效及对血清免疫水平和氨基酸代谢的影响. 中国医药导报. 2024(01): 92-95 .
    6. 李美华,王琳琳,耿小蕾. 基于Orem自护理论的护理干预结合叙事护理对慢性阻塞性肺疾病患者的影响. 心理月刊. 2024(03): 158-160 .
    7. 江远义,高应亮. 头孢哌酮舒巴坦联合二羟丙茶碱对慢阻肺急性加重期患者症状改善及CAT评分的影响. 临床医学工程. 2024(04): 435-436 .
    8. 唐敏,蒋德军,王朝亮,张良. 清金贝蒌汤加减联合布地奈德治疗痰热郁肺型慢性阻塞性肺疾病患者的临床观察. 世界中西医结合杂志. 2024(04): 725-729+736 .
    9. 武光瑞,黄海臣. 支气管肺泡灌洗联合比阿培南降阶梯疗法对慢性阻塞性肺疾病伴重症肺炎患者炎症因子及肺功能的影响. 中国合理用药探索. 2024(06): 50-56 .
    10. 周岩,许会平,谢中兰. 通腑泻肺法辅助西医治疗对慢性阻塞性肺疾病急性加重期患者CAT评分及T淋巴细胞亚群的影响. 黑龙江医药科学. 2024(04): 49-52 .
    11. 李颖,顾国忠,侯衍修,朱英娟,王培培. mMRC评分联合血清炎性因子水平对慢性阻塞性肺疾病患者急性加重风险的评估价值. 临床肺科杂志. 2024(09): 1360-1367 .
    12. 马苗苗. COPD合并肺心病患者凝血、血气分析变化与预后的相关性探讨. 航空航天医学杂志. 2024(09): 1067-1070 .
    13. 丁荣,张勇,吴凌华. 规范化管理在慢性阻塞性肺疾病缓解期患者中的应用效果. 临床医学研究与实践. 2024(26): 42-45 .
    14. 鲁雪红,康淑琴,栾丽. 肺高分辨率CT测定支气管壁增厚与慢性阻塞性肺疾病病情严重程度及其疗效的关系. 中国医学装备. 2024(09): 38-41 .
    15. 王辉,康肖菲,郭立娟,冯淬灵. 慢性阻塞性肺疾病患者血清CatS、CatL、CatB与炎性因子、CAT评分及预后的相关性研究. 西部医学. 2024(12): 1798-1802 .
    16. 江岚,江梅生,万红敏. 慢性阻塞性肺疾病患者血清25羟基维生素D与肺功能的相关性. 中国当代医药. 2023(02): 62-65 .
    17. 段菲,赵士红,孙小卫,肖江琴. 老年慢性阻塞性肺疾病患者衰弱及衰弱前期影响因素分析. 中华老年多器官疾病杂志. 2023(02): 91-96 .
    18. 郑双双,赵静,陈雪丽. 网络平台互动下的正念干预联合家庭肺康复训练对慢性阻塞性肺疾病患者肺功能、生活质量和焦虑抑郁情绪的影响. 中国当代医药. 2023(09): 63-68 .
    19. 潘玉嫦,罗哲,黄玉娥,罗瑞芬,卢凤华. 保护动机理论指导下的信息-动机-行为干预重度以上慢性阻塞性肺疾病患者的效果分析. 中国社区医师. 2023(07): 31-34 .
    20. 段菲,孙小卫,肖江琴,刘伟. 老年慢性阻塞性肺疾病患者老化期望现状及影响因素分析. 中国护理管理. 2023(04): 517-522 .
    21. 张伟荣,吴柳娇. 布地格福吸入气雾剂联合多索茶碱治疗慢性阻塞性肺疾病稳定期患者的效果. 慢性病学杂志. 2023(04): 600-603 .
    22. 王君妍,徐静. 信息-动机-行为技巧模型管理在稳定期重度COPD病人中的应用. 循证护理. 2023(20): 3762-3766 .
    23. 刘佳敏,谢逍,李梅. 纤维支气管镜联合氨溴索治疗COPD伴呼吸衰竭疗效及对血气指标、肺功能和血乳酸水平的影响. 中华肺部疾病杂志(电子版). 2023(05): 640-644 .
    24. 孙珍平,王俊明,罗晓东,郝瑞,史宝林. COPD患者血清锌含量变化及其与CAT评分的关系. 河北北方学院学报(自然科学版). 2022(02): 10-12+15 .
    25. 代钦,那仁满都拉,高笑宇,水兰,查松其其格,孙德俊. 慢性阻塞性肺疾病蒙医证型与临床指标的相关性研究. 中国医药. 2022(03): 403-406 .
    26. 郭月,管癸芬,陈海燕,陈燕霞,黄华兴. 慢性阻塞性肺疾病患者基于微信的三主体双轨道交互式护理. 护理学杂志. 2022(05): 84-87 .
    27. 严飞飞,徐旭东,张海波,姬亚锋. 健脾通络汤治疗慢性阻塞性肺疾病合并抑郁症的效果研究. 中华全科医学. 2022(07): 1211-1214 . 本站查看

    Other cited types(4)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (443) PDF downloads(13) Cited by(31)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return